In the initial discovery of a drug, it can take cancer researchers up to two years to narrow down 10,000 molecules to find the most effective ones that will safely cross the blood-brain barrier to kill cancer cells. But now, with artificial intelligence, the process can take researchers less than a week.
Panna Sharma, the CEO of oncology drug company Lantern Pharma, says utilizing AI can compress the time it takes to develop novelty drug molecules by 70-80%.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.